354 related articles for article (PubMed ID: 28813659)
1. The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression.
Pan W; Zhu S; Qu K; Meeth K; Cheng J; He K; Ma H; Liao Y; Wen X; Roden C; Tobiasova Z; Wei Z; Zhao J; Liu J; Zheng J; Guo B; Khan SA; Bosenberg M; Flavell RA; Lu J
Immunity; 2017 Aug; 47(2):284-297.e5. PubMed ID: 28813659
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M
Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851
[TBL] [Abstract][Full Text] [Related]
4. DNA methylcytosine dioxygenase ten-eleven translocation 2 enhances lipopolysaccharide-induced cytokine expression in human dental pulp cells by regulating MyD88 hydroxymethylation.
Wang X; Feng Z; Li Q; Yi B; Xu Q
Cell Tissue Res; 2018 Aug; 373(2):477-485. PubMed ID: 29654353
[TBL] [Abstract][Full Text] [Related]
5. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
6. TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression.
Bonvin E; Radaelli E; Bizet M; Luciani F; Calonne E; Putmans P; Nittner D; Singh NK; Santagostino SF; Petit V; Larue L; Marine JC; Fuks F
Cancer Res; 2019 Feb; 79(3):482-494. PubMed ID: 30538121
[TBL] [Abstract][Full Text] [Related]
7. TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2
Li R; Zhou Y; Cao Z; Liu L; Wang J; Chen Z; Xing W; Chen S; Bai J; Yuan W; Cheng T; Xu M; Yang FC; Zhao Z
Stem Cell Reports; 2018 Jan; 10(1):166-179. PubMed ID: 29290626
[TBL] [Abstract][Full Text] [Related]
8. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
9. TET2 promotes IL-1β expression in J774.1 cell through TLR4/MAPK signaling pathway with demethylation of TAB2 promoter.
Liang Y; Zeng J; Luo B; Li W; He Y; Zhao W; Hu N; Jiang N; Luo Y; Xian Y; Liu J; Zheng X
Mol Immunol; 2020 Oct; 126():136-142. PubMed ID: 32823238
[TBL] [Abstract][Full Text] [Related]
10. TET2 promotes anti-tumor immunity by governing G-MDSCs and CD8
Li S; Feng J; Wu F; Cai J; Zhang X; Wang H; Fetahu IS; Iwanicki I; Ma D; Hu T; Liu H; Wang B; Shi G; Tan L; Shi YG
EMBO Rep; 2020 Oct; 21(10):e49425. PubMed ID: 32929842
[TBL] [Abstract][Full Text] [Related]
11. Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma.
Gambichler T; Sand M; Skrygan M
Melanoma Res; 2013 Jun; 23(3):218-20. PubMed ID: 23458759
[TBL] [Abstract][Full Text] [Related]
12. TET2-Mediated Spatiotemporal Changes of 5-Hydroxymethylcytosine During Organogenesis in the Late Mouse Fetus.
Li X; Xie F; Jin J; Wu Y; Luo Z; Zhang F; Zhang S; Chen D; Liu A
Anat Rec (Hoboken); 2019 Jun; 302(6):954-963. PubMed ID: 30369084
[TBL] [Abstract][Full Text] [Related]
13. An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis.
Cheng J; Guo S; Chen S; Mastriano SJ; Liu C; D'Alessio AC; Hysolli E; Guo Y; Yao H; Megyola CM; Li D; Liu J; Pan W; Roden CA; Zhou XL; Heydari K; Chen J; Park IH; Ding Y; Zhang Y; Lu J
Cell Rep; 2013 Oct; 5(2):471-81. PubMed ID: 24120864
[TBL] [Abstract][Full Text] [Related]
14. [Functional analysis of TET2 using a knockdown mouse model].
Shide K; Kameda T; Shimoda K
Rinsho Ketsueki; 2015 Jun; 56(6):657-65. PubMed ID: 26256876
[TBL] [Abstract][Full Text] [Related]
15. Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE-/- mice.
Peng J; Yang Q; Li AF; Li RQ; Wang Z; Liu LS; Ren Z; Zheng XL; Tang XQ; Li GH; Tang ZH; Jiang ZS; Wei DH
Oncotarget; 2016 Nov; 7(47):76423-76436. PubMed ID: 27821816
[TBL] [Abstract][Full Text] [Related]
16. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.
Fujimura T; Aiba S
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32707850
[TBL] [Abstract][Full Text] [Related]
17. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
[TBL] [Abstract][Full Text] [Related]
18. TET2- and TDG-mediated changes are required for the acquisition of distinct histone modifications in divergent terminal differentiation of myeloid cells.
Garcia-Gomez A; Li T; Kerick M; Català-Moll F; Comet NR; Rodríguez-Ubreva J; de la Rica L; Branco MR; Martín J; Ballestar E
Nucleic Acids Res; 2017 Sep; 45(17):10002-10017. PubMed ID: 28973458
[TBL] [Abstract][Full Text] [Related]
19. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6.
Zhang Q; Zhao K; Shen Q; Han Y; Gu Y; Li X; Zhao D; Liu Y; Wang C; Zhang X; Su X; Liu J; Ge W; Levine RL; Li N; Cao X
Nature; 2015 Sep; 525(7569):389-393. PubMed ID: 26287468
[TBL] [Abstract][Full Text] [Related]
20. TET2 Negatively Regulates Nestin Expression in Human Melanoma.
Gomes CB; Zechin KG; Xu S; Stelini RF; Nishimoto IN; Zhan Q; Xu T; Qin G; Treister NS; Murphy GF; Lian CG
Am J Pathol; 2016 Jun; 186(6):1427-34. PubMed ID: 27102770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
